ABSTRACT
Study Objectives Night work plays an irreplaceable role in healthcare systems. However, sleep loss due to night shifts can negatively affect healthcare workers’ cognition. Identifying individual variables predicting night shift tolerance may help to mitigate the negative consequences of sleep loss on workers’ and patients’ safety. This study aims to explore, in a healthcare workers’ sample, which variables predict the possible impairment in sustained attention and increase in risk-taking behavior after a night shift.
Methods 22 healthcare workers (avg. age 39.4 ± 11.5 y, 63% females) participated in the experiment. Participants wore a wrist actigraph during a night shift and the preceding 6 days. At the beginning (t0) and at the end (t1) of the night shift, they underwent an assessment of sustained attention (Psychomotor Vigilance Task, PVT) and risk-taking behavior (Balloon Analogue Risk Task, BART). Questionnaires on risk propensity (Domain-Specific Risk Taking, DOSPERT) and on demographics were also administered. Linear regression models were estimated to disentangle the effect of age, risk propensity and actigraphically-defined sleep metrics on cognitive variables.
Results Wake after sleep onset (WASO) significantly predicted t1-t0 PVT metric “major lapses” (β=-0.11, p=0.0007) while age and DOSPERT significantly predicted t1-t0 BART score (β=-0.26, p=0.023 and β=-0.097, p=0.043, respectively).
Conclusions Sleep parameters predict the impairment in sustained attention, while the combination of age and risk propensity predicts an increase in risk-taking behavior. The implementation of measures to prevent cognitive decline during night shifts should be designed according to the type of tasks workers must accomplish.
- Decision making
- health policy
- health services research
- patient safety
Competing Interest Statement
Ugo Faraguna is Presidente and co-founder of sleepActa S.r.l., a spin-off company of the University of Pisa operating in the field of sleep medicine
Funding Statement
No external funding supported the work presented
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study has received the approval of the Bioethical Committee of the University of Pisa on August the 30th, with protocol number 0098770/2019.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data underlying this article cannot be shared publicly for the privacy of individuals that participated in the study. The data will be shared on reasonable request to the corresponding author.
